EcoDrugPlus

Protein Arginine Methyltransferase 5

Ensembl ID : ENSPNAG00000021904
Gene Symbol: PRMT5
3 Cross references
198 Possible Orthologues:

Protein Farnesyltransferase Subunit Beta-Like

Ensembl ID : ENSPNAG00000011222
Gene Symbol: LOC108424508
3 Cross references
209 Possible Orthologues:

Protein Kinase C Alpha

Ensembl ID : ENSPNAG00000029815
Gene Symbol: PRKCA
3 Cross references
213 Possible Orthologues:

Protein Kinase C Beta

Ensembl ID : ENSPNAG00000014653
Gene Symbol: PRKCB
3 Cross references
221 Possible Orthologues:

Protein Kinase C Beta Type

Ensembl ID : ENSPNAG00000023614
Gene Symbol: LOC108413382
3 Cross references
202 Possible Orthologues:

Protein Kinase C Delta

Ensembl ID : ENSPNAG00000002824
Gene Symbol: PRKCD
3 Cross references
203 Possible Orthologues:

Protein Kinase C Delta Type-Like

Ensembl ID : ENSPNAG00000015889
Gene Symbol: LOC108440644
3 Cross references
203 Possible Orthologues:

Protein Kinase C Epsilon

Ensembl ID : ENSPNAG00000002772
Gene Symbol: PRKCE
3 Cross references
261 Possible Orthologues:

Protein Kinase C Epsilon

Ensembl ID : ENSPNAG00000009835
Gene Symbol: PRKCE
3 Cross references
255 Possible Orthologues:

Protein Kinase C Eta Type-Like

Ensembl ID : ENSPNAG00000028009
Gene Symbol: LOC108434990
3 Cross references
158 Possible Orthologues:

Protein Kinase C Iota

Ensembl ID : ENSPNAG00000010579
Gene Symbol: PRKCI
3 Cross references
87 Possible Orthologues:

Protein Kinase C Theta

Ensembl ID : ENSPNAG00000030064
Gene Symbol: PRKCQ
3 Cross references
204 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).